$IMA
ImageneBio, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
ImageneBio, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is IMA down today? It is at $3.92 (-1.51%), and our scanner flagged it 11 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment IMA spikes, and full due diligence on IMA — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $IMA 11 times in the last 30 days. Create a free account to track $IMA, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
The market is closed. Here is how IMA traded in the last session, Friday (last price and move above). Our scanner fired 3 unusual-volume and momentum alerts on IMA on Friday, peaking at 130.7x its normal volume.
Likely catalystImageneBio Reports Third Quarter 2026 Financial ResultsReported As of September 30, 2026, the Company held $126.6 million in cash, cash equivalents and marketable securities, providing anticipated funding for planned operations into the first quarter of 2028.Reported Expenses: R&D expenses were $11.3 million for the three months ended September 30, 2026, compared to $15.2 million for the same period in 2025.Reported General and Administrative (G&A) Expenses: G&A expenses were $6.0 million for the three months ended September 30, 2026, compared to $11.0 million for the same period in 2025., from an SEC filing. Read it →Latest filingSC 13G/APassive 5%+ stake updatedNov 13, 2026 · 8 days agoAcross every filing on file, supply equal to 33.3% of the tradeable float is in play - 33.3% more can still be issued.
Shelf sizes are dollars, so shares are estimated at today's price.
Prospectus update and an active shelf on file: the company can issue new shares
2,508,337 new shares
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Grant-Huerta Yanina Officer | Acquired (grant/award) | +104K 0.8% of company | n/a | 104K | n/a | Aug 14, 26 |
Yarema Kristin Officer | Acquired (grant/award) | +255K 2.0% of company | added 100% | 494K | n/a | Aug 14, 26 |
Yarema Kristin Officer | Acquired (grant/award) | +115K 0.9% of company | added 93% | 239K | n/a | Jul 25, 26 |
Yarema Kristin Officer | Other | 38K 0.3% of company | added 45% | 124K | n/a | Jul 25, 26 |
Lally Robert B Officer | Sold (automatic/other) | -2K 0.01% of company | sold 2.7% | 56K | $8K at $5.34 | Jul 17, 26 |
Lally Robert B Officer | Sold (automatic/other) | -2K 0.01% of company | sold 2.8% | 57K | $9K at $5.50 | Jul 16, 26 |
Yarema Kristin Officer | Acquired (grant/award) | +85K 0.7% of company | n/a | 85K | n/a | Mar 16, 26 |
Butler Erin Officer | Acquired (grant/award) | +23K 0.2% of company | added 100% | 26K | n/a | Dec 30, 25 |
Slattery Joseph P Director | Bought (open market) | +16K 0.1% of company | n/a | 16K | $96K at $5.99 | Dec 24, 25 |
Marango Jotin Officer | Acquired (grant/award) | +16K 0.1% of company | n/a | 16K | n/a | Jul 28, 25 |
Marango Jotin Officer | Sold (automatic/other) | -5K 0.04% of company | sold 29% | 11K | $79K at $17.16 | Jul 28, 25 |
Butler Erin Officer | Acquired (grant/award) | +3K 0.02% of company | n/a | 3K | n/a | Jul 25, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in biological products, (no diagnostic substances), closest in size first.
The market is closed. Here is how IMA traded in the last session, Friday (last price and move above). Our scanner fired 3 unusual-volume and momentum alerts on IMA on Friday, peaking at 130.7x its normal volume.
IMA last traded at $3.92, down 1.51% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The IMA Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged IMA 11 times in the last 30 days.
IMA (ImageneBio, Inc. Common Stock) trades on XNAS, with a market cap of about $49M in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge IMA for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$IMA discussion
Sign in to ask a question or join the discussion.